About Deepbridge Life Sciences EIS
The Deepbridge Life Sciences EIS fund invests in growth-focused life-sciences companies, with Deepbridge taking an active role in guiding and mentoring the management team of the businesses it invests in. The investment strategy is to invest in a diversified portfolio of companies in the biopharmaceuticals, biotechnology and medical-technology sectors. The EIS has a target portfolio size of eight companies and a minimum subscription of £10,000. The target return is £1.70 for every £1 invested.
|Fund Manager:||Deepbridge Capital|
|Sector Focus:||Biotech, Medtech, and Pharma|
|Target Portfolio Size:||8 companies|
|Website:||Learn more about Deepbridge Life Sciences EIS|
About Deepbridge Capital
Launched in 2010, Deepbridge helps build growth businesses, along with a network of investors, technology advisers and industry partners. To date, it has helped to create more than 300 jobs through its investments into companies.
Deepbridge focuses on the technology, life sciences and renewable-energy sectors. It looks for businesses that are innovative and scalable, with the potential to be global; able to demonstrate customer interest and market traction; and which have an energetic and experienced management team.
How does SyndicateRoom's Access EIS Fund compare?
By comparison, SyndicateRoom's Access EIS fund builds investors a large portfolio of 50+ companies across all sectors, co-investing with experienced angel investors who have an average IRR of 42%. Our model is based on our proprietary analysis of the UK startup market, which showed that on average, the market grows by 28% each year. With large portfolios, and a large network of angels providing access to the best deals, earlier, we aim to replicate that annual growth for our investors while mitigating risk. This data-driven approach aims to work around the limitations of a single fund manager attempting to pick winners.
Our minimum investment is £5,000.
|Sector Focus:||Sector Agnostic|
|Target Portfolio Size:||50+ companies|
|Website:||Learn more about the Access EIS Fund|
Are you the fund manager? Email [email protected] with any comments or amends.